Who are Melatonin treatment's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Melatonin(Circadin®), Melatonin Patches, transdermal therapeutic system- melatonin., Melatonin injection, melatonin in children premedication, Ramelteon (RozeremR).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/melatonin-treatment.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-09 · How we verify

Melatonin treatment — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Melatonin treatment (Melatonin treatment) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Melatonin receptor agonist. Area: Neurology / Sleep Medicine.

marketed Melatonin receptor agonist MT1 and MT2 melatonin receptors Neurology / Sleep Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Melatonin treatment (Melatonin treatment) — Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health. Melatonin is a naturally occurring hormone that binds to melatonin receptors to regulate circadian rhythm and promote sleep.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Melatonin treatment TARGET	Melatonin treatment	Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
Melatonin(Circadin®)	Melatonin(Circadin®)	KIMJisun	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
Melatonin Patches	Melatonin Patches	Ain Shams University	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
transdermal therapeutic system- melatonin.	transdermal therapeutic system- melatonin.	Ain Shams University	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
Melatonin injection	Melatonin injection	Imperial College London	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
melatonin in children premedication	melatonin in children premedication	Azienda Ospedaliera Universitaria Policlinico "G. Martino"	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors
Ramelteon (RozeremR)	Ramelteon (RozeremR)	University of Sao Paulo	marketed	Melatonin receptor agonist	MT1 and MT2 melatonin receptors

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Melatonin receptor agonist class)

Ain Shams University · 2 drugs in this class
Al-Azhar University · 1 drug in this class
Azienda Ospedaliera Universitaria Policlinico "G. Martino" · 1 drug in this class
B.P. Koirala Institute of Health Sciences · 1 drug in this class
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health · 1 drug in this class
Hospital San Carlos, Madrid · 1 drug in this class
Imperial College London · 1 drug in this class
KIMJisun · 1 drug in this class
Rush University Medical Center · 1 drug in this class
Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Melatonin treatment — Competitive Intelligence Brief. https://druglandscape.com/ci/melatonin-treatment. Accessed 2026-06-09.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing